Previous 10 | Next 10 |
Source: marketbeat In March, the obscure biotech company Akers Biosciences (AKER) became known to a larger number of investors on the news it had entered into a licensing deal with Premas Biotech to work together on developing a vaccine to treat COVID-19, including Akers' expertise in ...
Gainers: Independence Contract Drilling (NYSE: ICD ) +204% . More news on: Independence Contract Drilling, Inc., Pluristem Therapeutics Inc., Nautilus, Inc., Stocks on the move, , Read more ...
Thorofare, New Jersey, April 08, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that its collaboration with Premas Biotech has successfully completed a second milestone, the...
April 8, 2020 Palm Beach, FL – April 8, 2020 – The search for vaccines and treatments for the global health crises is now focusing on medicines that are presently approved for other ailments. A recent article in the LA Times discussed this issue saying that when ...
Akers Biosciences ( AKER +27.1% ) inks agreements with several institutional and accredited investors for the sale of 766,667 common shares at $6.00 per share. Gross proceeds should be $4.6M. More news on: Akers Biosciences, Inc., Healthcare stocks news, , Stocks on the move, Read ...
Thorofare, New Jersey, April 07, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it has entered into definitive agreements with several institutional and accredited inve...
Sasol (NYSE: SSL ) +47% . More news on: Sasol Limited, Cherry Hill Mortgage Investment Corporation, Can-Fite BioPharma Ltd., Stocks on the move, , Read more ...
Gainers: Immunomedics (NASDAQ: IMMU ) +90% . More news on: Immunomedics, Inc., Akers Biosciences, Inc., Exantas Capital Corp., Stocks on the move, , Read more ...
Thinly traded nano cap Akers Biosciences ( AKER +62.4% ) rallies on a healthy 25x surge in volume in reaction to the advancement of its COVID-19 vaccine candidate. More news on: Akers Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Successfully obtained clones for all three selected Coronavirus Antigens Thorofare, New Jersey, April 06, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that its coll...
News, Short Squeeze, Breakout and More Instantly...
Akers Biosciences Inc. Company Name:
AKER Stock Symbol:
NASDAQ Market:
Akers Biosciences Inc. Website:
FORT WORTH, Texas, April 29, 2021 (GLOBE NEWSWIRE) -- Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) today announced the appointment of Karen Simon and Janet Pasque to its Board of Directors (the “Board”) effective...
Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol " MYMD " Upon Closing, the Combined Company will focus on developing and commercializing novel immunotherapy pipeline assets, including its lead molecule MYMD-1 ...
Akers Biosciences, Inc. (NASDAQ: AKER), today announced that its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”), a clinical stage pharmaceutical company committed to extending health lifespan and treating immune mediated illnesses, has reached an agreement...